Hyperglycemia
Conditions
Keywords
continuous glucose monitoring；, critically ill;
Brief summary
The purpose of the study is to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
Detailed description
Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
Interventions
OTHERDifferent methods of blood glucose monitoring between groups
Finger prick blood glucose in conventional group versus real-time continuous glucose monitoring system of continuous glucose monitoring group
Sponsors
Kang Yan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* More than 18 years old male or female; * Expected ICU stays longer than 72 hours; * Glucose level more than 8 mmol/L when enrolls in the ICU; * Patients or their legal surrogates have signed the informed consent.
Exclusion criteria
* Pregnant or lactating women; * ICU stays less than 72 hours; * Usage of real-time continuous glucose monitoring system is considered as a contraindication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycemic Control Measures including: Percentage of target blood glucose levels (defined as between 8mmol/L and 10mmol/L); Time of hyperglycemia (defined as >10mmol/L); Hypoglycemia rate (defined as < 2.2mmol/L); Glucose lability index | Glycemic control measures will be assessed up to five days. |
Secondary
| Measure | Time frame |
|---|---|
| Prognosis Measures including: Duration of mechanical ventilation；Time of ICU stay; Time of hospital stay; 28 days - mortality rate | All the participants will be followed for the duration of hospital stay or 28 days. |
| Cost | Cost associated with glucose monitoring |
Countries
China
Contacts
Primary ContactYan Kang, MD
Backup ContactYan-yan Zuo, MM
Outcome results
None listed